[go: up one dir, main page]

ES2160985T3 - Ensayos de tipo sandwich para fragmentos de colageno. - Google Patents

Ensayos de tipo sandwich para fragmentos de colageno.

Info

Publication number
ES2160985T3
ES2160985T3 ES97953745T ES97953745T ES2160985T3 ES 2160985 T3 ES2160985 T3 ES 2160985T3 ES 97953745 T ES97953745 T ES 97953745T ES 97953745 T ES97953745 T ES 97953745T ES 2160985 T3 ES2160985 T3 ES 2160985T3
Authority
ES
Spain
Prior art keywords
sandwich type
collagen fragments
type tests
collagen
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97953745T
Other languages
English (en)
Inventor
Christian Rosenquist
Per Qvist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunodiagnostic Systems Nordic AS
Original Assignee
Osteometer Biotech AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9625559.1A external-priority patent/GB9625559D0/en
Priority claimed from GBGB9705687.3A external-priority patent/GB9705687D0/en
Application filed by Osteometer Biotech AS filed Critical Osteometer Biotech AS
Application granted granted Critical
Publication of ES2160985T3 publication Critical patent/ES2160985T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/108—Osteoporosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Paints Or Removers (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

SE REALIZAN ENSAYOS EN EMPAREDADO DE PRODUCTOS DE DEGRADACION DEL COLAGENO, USANDO UN ANTICUERPO DE LA MISMA ESPECIFICIDAD EN AMBOS LADOS DEL EMPAREDADO, O USANDO UN PRIMER ANTICUERPO QUE REACCIONA CON UN EPITOPE CONTENIDO EN LA SECUENCIA EKAHDGGR Y UN SEGUNDO ANTICUERPO QUE PUEDE SER EL MISMO O DIFERENTE.
ES97953745T 1996-12-09 1997-12-05 Ensayos de tipo sandwich para fragmentos de colageno. Expired - Lifetime ES2160985T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9625559.1A GB9625559D0 (en) 1996-12-09 1996-12-09 Sandwish assays for collagen type I fragments
GBGB9705687.3A GB9705687D0 (en) 1997-03-19 1997-03-19 Sandwich assays for collagen type i fragments

Publications (1)

Publication Number Publication Date
ES2160985T3 true ES2160985T3 (es) 2001-11-16

Family

ID=26310589

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97953745T Expired - Lifetime ES2160985T3 (es) 1996-12-09 1997-12-05 Ensayos de tipo sandwich para fragmentos de colageno.

Country Status (8)

Country Link
US (2) US6660481B2 (es)
EP (1) EP0944833B1 (es)
JP (1) JP3913787B2 (es)
AT (1) ATE202632T1 (es)
AU (1) AU5754298A (es)
DE (1) DE69705423T2 (es)
ES (1) ES2160985T3 (es)
WO (1) WO1998026286A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962639A (en) * 1987-11-06 1999-10-05 Washington Research Foundation Synthetic peptides corresponding to telopeptide sequences of cross-linked type I collagen metabolites
WO1998026286A2 (en) * 1996-12-09 1998-06-18 Osteometer Biotech A/S Sandwich assays for collagen type i fragments
US7354723B2 (en) 1999-11-26 2008-04-08 Nordic Bioscience Dagnostics A/S Assay of isomerised and/or optically inverted proteins and protein fragments
GB9928052D0 (en) * 1999-11-26 2000-01-26 Osteometer Biotech As Assay of isomerised and/or optically inverted proteins and protein fragments
WO2002008722A2 (en) * 2000-07-12 2002-01-31 Werner Naser Direct assessment of relative concentrations of variants of an epitope on a dimeric molecule
US7267958B2 (en) * 2001-11-01 2007-09-11 Rensselaer Polytechnic Institute Biocatalytic solgel microarrays
US20050124071A1 (en) * 2003-09-30 2005-06-09 Kraus Virginia B. Methods and compositions for diagnosing musculoskeletal, arthritic and joint disorders by biomarker dating
JP4959710B2 (ja) * 2005-11-01 2012-06-27 レンセレアー ポリテクニック インスティテュート 毒物学アッセイのための３次元細胞アレイチップおよびプラットフォーム
WO2009038771A2 (en) * 2007-09-19 2009-03-26 Massachusetts Institute Of Technology Tolperisone and tolperisone-like drugs for the treatment of k-ras associated cancers
EP2223112A2 (en) * 2007-12-21 2010-09-01 Siemens Healthcare Diagnostics Inc. Circulating epha2 receptor
US8796184B2 (en) 2008-03-28 2014-08-05 Sentilus, Inc. Detection assay devices and methods of making and using the same
WO2013158217A1 (en) * 2012-04-20 2013-10-24 Thomas Jefferson University Engineered antibody for inhibition of fibrosis
US9753030B2 (en) * 2013-03-06 2017-09-05 University of Pittsburgh—of the Commonwealth System of Higher Education Degradable carbon nanotube-containing biosensors and methods for target clinical marker detection
ES2687220B1 (es) * 2017-03-23 2019-08-08 Servicio Andaluz De Salud Método de obtención de datos útiles para el cribado y diagnóstico de la osteoporosis
EP4317172A4 (en) * 2021-03-24 2025-03-05 Sekisui Medical Co., Ltd. IMMUNOLOGICAL ANALYSIS METHOD FOR TYPE I COLLAGEN C-TERMINAL TLOPEPTIDE
JPWO2023068249A1 (es) * 2021-10-20 2023-04-27

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6716836A (es) 1967-12-11 1969-06-13
DE2816841A1 (de) 1978-04-18 1979-10-31 Max Planck Gesellschaft Radioimmunologische bestimmung von prokollagen (typ iii) und prokollagen- peptid (typ iii)
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
DE3209149A1 (de) 1982-03-13 1983-10-06 Hoechst Ag Verfahren zur gemeinsamen immunologischen bestimmung von prokollagen-peptid (typ iii) und prokollagen-peptid col 1 (typ iii) und verfahren zur herstellung von anti-prokollagen-peptid col 1 (typ iii)-serum
CA1251729A (en) 1982-05-19 1989-03-28 Steffen Gay In vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
US4628027A (en) 1982-05-19 1986-12-09 Molecular Engineering Associates, Ltd. Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
SE8304836D0 (sv) 1983-09-09 1983-09-09 Pharmacia Ab Sett att bestemma forendringar i ledbrosk
US5001225A (en) 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
JPS63209318A (ja) 1987-02-26 1988-08-30 Sony Corp 受信機
DE3714634A1 (de) 1987-05-02 1988-11-17 Hoechst Ag Verfahren zur selektiven immunologischen bestimmung von intaktem prokollagen peptid (typ iii) und prokollagen (typ iii) in koerperfluessigkeiten und mittel zu dessen durchfuehrung
US5679583A (en) 1987-05-02 1997-10-21 Hoechst Aktiengesellschaft Monoclonal antibodies for the selective immunological determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids
GB2205643B (en) 1987-05-08 1991-03-13 Farmos Group Limited Type iii collagen degradation assay
US5300434A (en) 1987-11-06 1994-04-05 Washington Research Foundation Hybridoma cell line producing an antibody to type-I collagen amino-terminal telopeptide
US5320970A (en) 1987-11-06 1994-06-14 Washington Research Foundation Detection of collagen degradation in vivo
US4973666A (en) 1987-11-06 1990-11-27 Washington Research Foundation Peptide fragments containing HP and LP cross-links
EP0339443B1 (de) 1988-04-27 1994-12-21 Hoechst Aktiengesellschaft Monoklonaler Antikörper zur selektiven immunologischen Bestimmung von intaktem Prokollagen Peptid (Typ III) und Prokollagen (Typ III) in Körperflüssigkeiten
GB8815174D0 (en) 1988-06-25 1988-08-03 Rowett Research Inst Method of monitoring collagen degradation
CA2001373A1 (en) 1988-10-24 1990-04-24 Bruce Caterson Methods and compositions for diagnosing, monitoring and treating the early stage of osteoarthritis
WO1990008195A1 (en) 1989-01-13 1990-07-26 President And Fellows Of Harvard College Monoclonal antibody to human type ix collagen
ZA909755B (en) 1989-12-07 1991-09-25 Res Dev Foundation Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product
GB9014220D0 (en) 1990-06-26 1990-08-15 Farmos Yhtymy Oy Method for the immunlolgical determinition of the carboxyterminal propeptide of type i procollagen
GB9105893D0 (en) 1991-03-20 1991-05-08 Orion Yhtymae Oy Bone resorption assay based on a peptide liberated during collagen degradation
DE4225038C2 (de) 1992-07-29 1995-11-30 Boehringer Mannheim Gmbh Herstellung und Verwendung von Antikörpern gegen Kollagen
JPH08505149A (ja) * 1992-12-28 1996-06-04 ジェイ． ベイリンク，デビッド 骨再吸収検定法
EP0711415B1 (de) 1993-07-28 1998-07-22 Boehringer Mannheim Gmbh Immunoassay zum nachweis von kollagen typ i oder kollagenfragmenten davon
DK104093D0 (da) 1993-09-17 1993-09-17 Osteometer A S Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
GB9506050D0 (en) 1995-03-24 1995-05-10 Osteometer A S Assaying collagen fragments in body fluids
JPH08100000A (ja) 1994-09-30 1996-04-16 Morinaga & Co Ltd ヒトｉｖ型コラーゲンに対する抗体及びその利用
ES2154739T3 (es) * 1994-10-17 2001-04-16 Osteometer Biotech As Estimacion del modelo de fragmentacion del colageno en fluidos corporales y el diagnostico de trastornos asociados con el metabolismo del colageno.
DE59505585D1 (de) 1994-12-23 1999-05-12 Roche Diagnostics Gmbh Antigene und Antikörper zum Nachweis von Kollagen I
US5763272A (en) 1994-12-23 1998-06-09 Boehringer Mannheim Gmbh Hybridoma for producing antibody for collagen I
US5750647A (en) 1995-05-19 1998-05-12 Washington Research Foundation Synthetic peptide analogs of NTx
JPH0921803A (ja) * 1995-07-07 1997-01-21 Teijin Ltd ２型コラーゲンテロペプチドの測定方法
US6107047A (en) * 1996-03-21 2000-08-22 Osteometer Biotech A/S Assaying protein fragments in body fluids
GB9617616D0 (en) 1996-08-22 1996-10-02 Osteometer Biotech As Assaying protein fragments in body fluids
JP3446493B2 (ja) 1996-09-13 2003-09-16 トヨタ自動車株式会社 エキゾーストマニホルド
EP0829724A1 (en) * 1996-09-17 1998-03-18 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Assay for detecting collagen degradation
WO1998026286A2 (en) * 1996-12-09 1998-06-18 Osteometer Biotech A/S Sandwich assays for collagen type i fragments
GB9702252D0 (en) * 1997-02-06 1997-03-26 Univ Sheffield Medical The Sch Collagen assay

Also Published As

Publication number Publication date
US7195883B2 (en) 2007-03-27
WO1998026286A3 (en) 1998-08-13
US6660481B2 (en) 2003-12-09
EP0944833A2 (en) 1999-09-29
DE69705423D1 (de) 2001-08-02
JP3913787B2 (ja) 2007-05-09
DE69705423T2 (de) 2002-05-16
AU5754298A (en) 1998-07-03
EP0944833B1 (en) 2001-06-27
ATE202632T1 (de) 2001-07-15
JP2001506000A (ja) 2001-05-08
US20040224375A1 (en) 2004-11-11
US20030148272A1 (en) 2003-08-07
WO1998026286A2 (en) 1998-06-18

Similar Documents

Publication Publication Date Title
ES2160985T3 (es) Ensayos de tipo sandwich para fragmentos de colageno.
BR8301376A (pt) Valvula para uso em uma coluna de teste de poco
ES2067604T3 (es) Anticuerpos frente a proteina que se une a tnf i y a sus fragmentos f(ab).
MX163813B (es) Procedimiento microbilogico para producir proteina heterologa en levaduras
FI953792A7 (fi) Immobilisoidut proteiinit, joilla on spesifiset sitoutumiskyvyt, ja niiden käyttö menetelmissä ja tuotteissa
ES2139012T3 (es) Peptidos de la proteina p53 humana destinados para ser utilizados en composiciones que inducen una reaccion en los linfocitos t humanos, y linfocitos t citotoxicos especificos de la proteina p53 humana.
AR225492A1 (es) Mejoras en una grapa hemostatica e instrumento para aplicarla
FI902143A7 (fi) HIV-peptidit, keinotekoiset HIV-antigeenit ja immunomäärityspakkaukset
BR9704709A (pt) Cavidade de amostra coberta para uso em ensaios de ácido nucleico e imunoensaios
BR8506817A (pt) Glicoproteina antigenica bovina,anticorpo relacionado e uso na deteccao de gravidez no gado
IL60961A (en) Beta-galactosyl-umbelliferone-labeled protein or polypeptide conjugates and their use in immunoassay methods
ES8507692A1 (es) Un procedimiento para preparar un trazador para uso en ensayo no isotopico
PT869970E (pt) Inibidor da proliferacao de celulas endoteliais e sua utilizacao
BR9506455A (pt) Reagente de detecção para uso em um ensaio de teste artigo de manufatura útil em um imunoensaio processo para capturar um parceiro de ligação de uma imunoglobina imunoensaio do tipo que emprega uma pluralidade de parceiros de ligação e kit
BR9802800A (pt) Nova composição para aperfeiçoar a fabricação de pães.
ATE182366T1 (de) Immunoassays für und monoklonale antikörper gegen prothrombin-aktivierende peptide und ihre abbauprodukte
BR9806195A (pt) Composição edulcorante solúvel contendo fibras alimentares, sua preparação e uso para objetivo alimentar.
ES2157979T3 (es) Titulacion inmunologica competitiva por medio de una proteina de union utilizada en una estructura de anticuerpos multiclonal.
ES2100960T3 (es) Estructura proteica de la toxina vegetal gelonina.
ES539223A0 (es) Mejoras intruducidas en un ensayo para determinar un antigeno bacteriano en una muestra de ensayo
ES2052913T3 (es) Ensayo inmunoquimico en cuanto al factor estimulante de colonias de granulocitos-macrofagos.
FI943218L (fi) Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja käytöt
AR224900A1 (es) Un conjunto de ensayo u.v.cinetico para la determinacion simultanea de transaminasa glutamica oxalacetica(got)y transaminasa glutamica piruvica(gpt)en una sola muestra de suero o plasma
KR930700548A (ko) 자궁내막 항체 측정방법 및 측정용 자궁내막 항원, 조성물, 테스트킷
FI905350A7 (fi) Leimattua streptokokki-vasta-ainetta sisältävä koostumus, testipakkaus ja analyysimenetelmä, jossa sitä käytetään

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 944833

Country of ref document: ES